MedTox’s medical drug monitoring program, Labcorp MedWatch®, provides unparalleled choice, flexibility, and clinical value for your specific monitoring needs and offers a comprehensive test menu with the ability to identify many unique metabolites within each drug class. Testing options include ToxAssure® Comprehensive, which identifies 26 drug categories and 180 drug compounds from a urine specimen, and ToxAssure® Select, which identifies 13 drug categories and 53 drug compounds from a urine specimen.
MedTox offers regulated and non-regulated drug-free workplace testing in its state-of-the-art laboratory that is certified by the Substance Abuse and Mental Health Services Administration (SAMHSA). In 1988, MedTox became one of the first 10 laboratories to be certified by the National Institute on Drug Abuse (NIDA).
MedTox operates a CAP- and CLIA-certified clinical laboratory that offers a variety of toxicology testing services including: blood drug profiles, meconium drug panels, therapeutic drug monitoring, synthetic/designer drugs and pharmaceutical quantitation.
The CDC estimates that 500,000 US children suffer from lead levels greater than the reference threshold at which public action is recommended. Requiring just two drops of blood, our in-office collection can help increase the number of patients being appropriately screened, thus allowing more patients to receive proper care.